Nantes Université, CHU Nantes, Chirurgie Cancérologique, Digestive et Endocrinienne, Institut des Maladies de l'Appareil Digestif.
Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax.
Int J Surg. 2023 Mar 1;109(3):364-373. doi: 10.1097/JS9.0000000000000282.
The impact of parathyroidectomy (PTX) for primary hyperparathyroidism (PHPT) on long-term quality of life (QoL) remains controversial. The study evaluated QoL changes 1 and 3 years after PTX.
Patients undergoing PTX for PHPT between 2016 and 2022 ( n =329) were enrolled in this monocentric, prospective cohort study. QoL was evaluated using the SF-36 questionnaire before, 1 year, and 3 years after PTX and compared with an age-matched and sex-matched French reference population. Only patients with 1-year and 3-year follow-up and complete evaluation (serum calcium, phosphorus, parathyroid hormone) were included.
A total of 159 patients were included (mean age: 62.6±12.7 years, 79.2% females). Mean serum calcium (2.66±0.20 mmol/l) and median parathyroid hormone (96.4 [76.9-126.4] pg/ml) levels improved significantly after PTX. Before surgery, PHPT patients had impaired physical (44.6±8.9 vs. 47.6±6.8 in the reference population, P <0.001) and mental (42.3±10.9 vs. 48.9±6.8, P <0.001) component scores. The mean physical component score increased significantly at 1 and 3 years and was no longer different from the reference population (ratio: 0.94±0.15 preoperatively vs. 0.99±0.15 at 3 years, P <0.01). The mean mental component score increased significantly at 1 and 3 years, but remained significantly lower than the reference population. Before surgery, a lower physical component score and younger age were significantly associated with a 3-year physical component score increase on multiple linear regression analysis.
A significant improvement in QoL is associated with PTX for PHPT at 1 year and is sustained for at least 3 years after surgery.
甲状旁腺切除术(PTX)治疗原发性甲状旁腺功能亢进症(PHPT)对长期生活质量(QoL)的影响仍存在争议。本研究评估了 PTX 后 1 年和 3 年的 QoL 变化。
本单中心前瞻性队列研究纳入了 2016 年至 2022 年间接受 PTX 治疗 PHPT 的 329 例患者。使用 SF-36 问卷评估 QoL,分别在 PTX 前、1 年和 3 年后进行,并与年龄和性别匹配的法国参考人群进行比较。仅纳入有 1 年和 3 年随访且完成评估(血清钙、磷、甲状旁腺激素)的患者。
共纳入 159 例患者(平均年龄:62.6±12.7 岁,79.2%为女性)。PTX 后血清钙(2.66±0.20mmol/l)和中位甲状旁腺激素(96.4[76.9-126.4]pg/ml)水平显著改善。术前 PHPT 患者的生理(44.6±8.9 与参考人群的 47.6±6.8,P<0.001)和心理(42.3±10.9 与参考人群的 48.9±6.8,P<0.001)评分均受损。1 年和 3 年后生理评分均显著升高,与参考人群无差异(比值:术前 0.94±0.15 与 3 年时 0.99±0.15,P<0.01)。心理评分也显著升高,但仍明显低于参考人群。术前,生理评分较低和年龄较小与多元线性回归分析中 3 年时的生理评分升高显著相关。
PTX 治疗 PHPT 可显著改善 QoL,且至少在术后 3 年内持续改善。